𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa in the treatment of Parkinson's disease: Current controversies


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
27 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The original article to which this Erratum refers was published in the September, 2004 issue of Movement Disorders (2004) 19 (9) 997–1005.


πŸ“œ SIMILAR VOLUMES


Levodopa in the treatment of Parkinson's
✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; U. Bonucelli; Phili πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 1 views

## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the β€œgold standard” against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor

Levodopa in the treatment of Parkinson's
✍ Manfred Gerlach; Heinz Reichmann; Peter Riederer πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 39 KB πŸ‘ 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.

Reply: Levodopa in the treatment of Park
✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 1 views

## Abstract The original articles to which this Letter refers have published in __Movement__ Disorders: Current Controversies: Levodopa in the Treatment of Parkinson's Disease, by Sharma, Vassallo, and Ross and Levodopa in the Treatment of Parkinson's Disease: Current Controversies, by Gerlach, Rei

Current controversies: Levodopa in the t
✍ Jagdish C. Sharma; M. Vassallo; I.N. Ross πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 48 KB πŸ‘ 1 views

## Abstract Companion letters have been published in __Movement__ Disorders: Levodopa in the Treatment of Parkinson's Disease: Current Controversies, by Gerlach, Reichmann, and Riederer and Reply: Levodopa in the Treatment of Parkinson's Disease, by Olanow, Agid, and Mizuno.